FDA 483 - RNA Coporation - December 19, 2025
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
RNA Corporation, a contract manufacturer in Blue Island, IL, received a Form 483 citing significant deficiencies in its quality control unit, particularly concerning electronic record audit trails and analytical raw data review. The inspection revealed a failure to follow established SOPs, a lack of raw data reviews, and untrained personnel for critical data integrity tasks. These issues indicate a systemic breakdown in data management and quality assurance processes.
ID · 957b3c6f-d071-4456-acbd-dca91c483106